News

Synthesis of tetracycline derivatives with novel substituents has been challenging. Using an approach based on a Michael-Dieckmann reaction, new compounds with enhanced antibiotic properties are now being prepared on a large scale.

Jubilant HollisterStier added an ampul filling line utilizing a rigid barrier system.

Till, a PhRMA vice president, will lead AAPS starting in November; Executive Council and Section leadership positions were also announced.

The expansion adds commercial specialty ligand, capacity manufacturing.

The initiative enables cleanroom and laboratory operators to recycle used protective garments.

The companies sign a nonexclusive research license agreement, giving Sorrento's access to Lonza's GS Xceed Gene Expression System.

ScinoPharm Changshu Pharmaceuticals and Sundia MediTech form an alliance for contract research and manufacturing services in mainland China.

Gallus Biopharmaceuticals has signed a development and manufacturing supply agreement with Genzyme.

Sanofi Chimie will supply the API avanafil for VIVUS.

The companies initially focused on five biosimilar products.

Lyophilization Services of New England (LSNE) received a Certificate of GMP Compliance for its New Hampshire facility.

Adamis Pharmaceuticals agrees to license and potentially acquire 3M's Taper Dry Powder Inhaler technology.

The guidance describes a risk-based approach to monitoring of clinical trials.

A new study reveals how a promising anticancer specifically kills prostate cancer cells by compromising their ability to withstand environmental stress.

Donaldson Company, Inc. announced a $10 million expansion of its testing laboratories at its Bloomington, Minn., corporate headquarters.

Advanced Clinical announced the appointment of Cheryle Evans as vice president, Clinical Operations.

America's biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological disorders, according to a new report released by PhRMA.

Singapore facility delivers manufacturing redundancy and increases supply assurance for global biologic drug discovery and production.

Weill Cornell scientists reveal how a protein drug eradicated human lymphoma in mice.

Edwards will oversee company's financial, logistical and human-resources operations.

Funding awarded to develop innovative solutions that address unmet health needs.

Additional investment from the Biomedical Catalyst will fund multiple programs in the UK.

Selected trendsetters reflect changes in the pharmaceutical industry.

Survey confirms strong link between choice of preferred central laboratory and investigator satisfaction with study sponsors.

A proposed new guideline provides a global policy for limiting metal impurities qualitatively and quantitatively in drug products and ingredients.

Nanomedicines have been authorized by European licensing agencies for more than 30 years but are still posing regulatory difficulties.

Orphan drugs for rare diseases are a major area of investment for pharmaceutical companies, but are they becoming too expensive for Europe to afford them?

Bristol-Myers Squibb Company and Samsung BioLogics announced the companies have entered into a 10-year agreement.

A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination.

Wyeth Pharmaceuticals has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by FDA.